Product Information
ZIDOVUDINE 50 MG/5 ML SYRUP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1499 per ML under NDC 65862004824. Its NADAC has been published 182 times since Nov 28, 2013.
FDA first approved this application on Sep 19, 2005. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862004824
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077268FDA Approved
9/19/2005
TE Code
AA
On Market Since
9/19/2005
Pharmacological Classes
Price Statistics
The NADAC for ZIDOVUDINE 50 MG/5 ML SYRUP has been published 182 times since Nov 28, 2013, and over the history we have for it it has risen 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1499 per ML |
|---|---|
| All-time high | $0.1499 (Sep 10, 2025) |
| All-time low | $0.1210 (Nov 28, 2013) |
| 52-week high | $0.1499 |
| 52-week low | $0.1499 |
| Median price | $0.1486 |
| Average price | $0.1464 |
| Largest weekly change | +18.4% (Jan 22, 2014) |
| Weeks tracked | 182 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
+0.9%
5Y
+0.9%
All
+23.9%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zidovudine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zidovudine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZIDOVUDINE 50 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 50 MG/5 ML SYRUP, manufactured by Aurobindo Pharma Limited, is $0.1499 per ML (NDC 65862004824), effective Sep 16, 2026.
How has the price of ZIDOVUDINE 50 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for ZIDOVUDINE 50 MG/5 ML SYRUP has risen 23.9%. It has been tracked across 182 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 50 MG/5 ML SYRUP?
Since Nov 28, 2013, the NADAC for ZIDOVUDINE 50 MG/5 ML SYRUP has ranged from a low of $0.1210 (Nov 28, 2013) to a high of $0.1499 (Sep 10, 2025), with a median of $0.1486 per ML.
Are there cheaper alternatives to ZIDOVUDINE 50 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of ZIDOVUDINE 50 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZIDOVUDINE 50 MG/5 ML SYRUP?
ZIDOVUDINE 50 MG/5 ML SYRUP (NDC 65862004824) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.